Sort
4,870 grants matching “glp 1”
Small molecule inhibitory leads against influenza RdRp
$705,833Thomas Roy Webb · Sri International · R01 · FY2015 · AI
Differential Spatial cAMP Signaling in the Pancreatic Beta cell
$705,817Mehboob A Hussain · University Of California-Irvine · R01 · FY2025 · DK
Pharmacogenetic discovery in the GRADE comparative effectiveness type 2 diabetes clinical trial
$704,872Jose Carlos Florez · Massachusetts General Hospital · R01 · FY2021 · DK
Increased Protein at Breakfast for Weight Management in Overweight Adolescents
$704,581Heather J Leidy · Purdue University · R01 · FY2016 · DK
Targeting timing of food intake as a novel strategy against disruption of blood pressure circadian rhythm in diabetes
$704,321Ming C Gong · University Of Kentucky · R01 · FY2019 · HL
A Simple and Implantable Device for the Treatment of Gastroesophageal Reflux Disease
$704,295Claude Nmn Tihon · Aplos Medical Inc · R44 · FY2015 · DK
Small molecule inhibitory leads against influenza RdRp
$704,283Thomas Roy Webb · Sri International · R01 · FY2014 · AI
Repurposing Semaglutide for the Treatment of Cocaine Use Disorder: a Pilot Mechanistic Study
$702,965Luba Yammine · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · DA
A novel approach for prevention of Bronchopulmonary dysplasia in at-risk pre-term infants
$702,096Suchismita Acharya · Ayuvis Research, Inc. · R44 · FY2023 · HD
A new radiopharmaceutical for the treatment of metastatic bone cancer
$701,849Jaime Nmn Simon · Isotherapeutics Group, Llc · R44 · FY2014 · CA
Brain systems and behaviors underlying response to obesity treatment in children
$701,841Christian Ludwig Roth · Seattle Children'S Hospital · R01 · FY2019 · DK
A Novel Recombinant Protein Vaccine Against Ricin Toxin
$701,754University Of Texas Sw Med Ctr/Dallas · U01 · FY2004 · AI
Bumped-Kinase Inhibitor Drug Development for Toxoplasmosis
$701,303Wesley C Van Voorhis · University Of Washington · R01 · FY2021 · HD
Coronary Post-Dilatation Catheter
$701,239William Combs · 3dt Holdings, Llc · R44 · FY2015 · HL
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans with Prediabetes
$701,211Absalon Dennis Gutierrez · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · DK
Early Screening of Breast Lesion Trial (Phase III Pivotal)
$701,169David A. Benaron · Spectros Corporation · R44 · FY2009 · CA
GLP-1 analogue effects on food cues, stress, motivation for highly palatable foods, and weight
$700,823Ania Jastreboff · Yale University · R01 · FY2020 · DK
Transplantation of Multipotent Progenitor Cells in Stroke
$700,496Cesario V Borlongan · University Of South Florida · U01 · FY2008 · NS
Institute of Human Virology H3Africa Biorepository (I-HAB)
$700,000Alash'le G. Abimiku · Institute Of Human Virology · U24 · FY2019 · HG
A single dose anti-scarring therapeutic for the cornea
$699,991Tere M. Williams · Dub Therapeutics Inc. · R44 · FY2023 · EY
Fluorescence Image-Guided Near Infrared (NIR) Photodynamic Therapy (PDT) Agent
$699,940Mykhaylo Dukh · Photolitec, Llc · R42 · FY2014 · CA
Obesity complicating type 1 diabetes in young people: Physiology and Impact of GLP-1 analogue anti-obesity treatment on cardiometabolic risk factors
$698,781Michelle Van Name · Yale University · R01 · FY2024 · DK
Validation of a Novel NF-kB Inhibitor in Inflammatory Bowel Disease
$698,128Anthony Thomas Blikslager · Theralogics, Inc. · R42 · FY2013 · DK
Validation of a Novel NF-kB Inhibitor in Inflammatory Bowel Disease
$698,128Scott E Plevy · Theralogics, Inc. · R42 · FY2012 · DK
Novel pharmacotherapy strategies for obesity in schizophrenia
$697,868Lars Fredrik Jarskog · Univ Of North Carolina Chapel Hill · R01 · FY2016 · DK